Evidence mapPaperPMID 32013202Full record

ArticleMarine drugs2020

Layanne C C Araujo, Aline F Brito, Iara L L Souza, Paula B Ferreira, Luiz Henrique C Vasconcelos, Alexandre S Silva, Bagnólia A Silva

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. International journal of molecular sciences · 2025
    Article
  3. Review
  4. Supplementation withMarine drugs · 2022
    Article
  5. Article
  6. Supplementation WithFrontiers in pharmacology · 2022
    Article
  7. Supplementation withNutrients · 2021
    Article
  8. Oxidative medicine and cellular longevity · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Layanne C C AraujoPrograma de Pós-graduação em Ciências (Fisiologia Humana), Instituto de Ciências Biológicas, Universidade de São Paulo, Sao Paulo/SP 05508900, Brazil.ORCID 0000-0002-2988-4175
Aline F BritoEscola de Educação Física, Universidade de Pernambuco, Recife/PE 50740-465, Brazil.
Iara L L SouzaPrograma de Pós-graduação em Produtos Naturais e Sintéticos Bioativos, Centro de Ciências da Saúde, Universidade Federal da Paraíba, Joao Pessoa/PB, 58051900, Brazil.
Paula B FerreiraPrograma de Pós-graduação em Produtos Naturais e Sintéticos Bioativos, Centro de Ciências da Saúde, Universidade Federal da Paraíba, Joao Pessoa/PB, 58051900, Brazil.
Luiz Henrique C VasconcelosPrograma de Pós-graduação em Produtos Naturais e Sintéticos Bioativos, Centro de Ciências da Saúde, Universidade Federal da Paraíba, Joao Pessoa/PB, 58051900, Brazil.ORCID 0000-0003-0161-4891
Alexandre S SilvaDepartamento de Educação Física, Centro de Ciências da Saúde, Universidade Federal da Paraíba, Joao Pessoa/PB 58051900, Brazil.ORCID 0000-0003-3576-9023
Bagnólia A SilvaPrograma de Pós-graduação em Ciências (Fisiologia Humana), Instituto de Ciências Biológicas, Universidade de São Paulo, Sao Paulo/SP 05508900, Brazil.
Universidade Federal da Paraíba · BRUniversidade de Pernambuco · BRUniversidade de São Paulo · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 433232/2016-1
6 · The paper itself

Abstract

The blue alga

Indexed as

Dietary SupplementsSpirulinaAnimalsAntioxidantsIleumMalondialdehydeOxidative StressRatsRats, WistarAntioxidantsMalondialdehydeblue algaecontractile reactivityileumoxidative stressSpirulina platensis

Identifiers

PMID32013202
PMCPMC7073603
OpenAlexW3004010619

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.